Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

NCT00533481 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

497

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: MK0557

Sponsor

Merck Sharp & Dohme LLC